Parnax Lab schedules 44th AGM on Sep 29 for RPT approval
- Parnax Lab holds 44th AGM on September 29, 2026
- Shareholders approve related-party deals with Naxpar Pharma
- Ladha Singhal & Associates appointed as statutory auditors
- Remote e-voting open from September 26 to 28, 2026

*this image is generated using AI for illustrative purposes only.
Parnax Lab has scheduled its 44th Annual General Meeting for September 29, 2026. The meeting will address the adoption of FY26 accounts and key governance matters.
The event will be conducted through Video Conferencing or Other Audio-Visual Means, as permitted by Ministry of Corporate Affairs circulars. Shareholders holding shares as of the record date, September 22, 2026, are eligible to vote.
Ordinary Business Agenda
The ordinary business includes the reappointment of Mr. Mihir M. Shah as a director. He retires by rotation and offers himself for reappointment. Mr. Shah holds 1,141,250 shares in the company as of March 31, 2026.
Additionally, shareholders will vote to appoint M/s. Ladha Singhal & Associates as the statutory auditors. The firm will serve a five-year term from the conclusion of this AGM until the 49th AGM.
Related Party Transactions
A special business item involves approving material related-party transactions with Naxpar Pharma Private Limited, a subsidiary of Parnax Lab. The transactions cover sales and purchases of materials and interest received on loans.
| Transaction Type | Value Limit | Duration |
|---|---|---|
| Sales of Materials | ₹5 crore per transaction | Oct 1, 2026 – Sep 30, 2027 |
| Purchase of Materials | ₹5 crore per transaction | Oct 1, 2026 – Sep 30, 2027 |
| Interest Received on Loan | ₹1.5 crore aggregate | Oct 1, 2026 – Sep 30, 2027 |
These arrangements are proposed for the financial years 2026-27 and 2027-28, valid until the next AGM in calendar year 2027. The Audit Committee has recommended these transactions, noting they are conducted at arm's length.
Voting Mechanism
Remote e-voting will be available from September 26, 2026, at 9:00 am to September 28, 2026, at 5:00 pm. The facility is provided by MUFG Intime India Private Limited. Shareholders can vote via NSDL, CDSL, or the InstaVote platform depending on their holding mode.
Historical Stock Returns for Parnax Lab
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.34% | +3.57% | 0.0% | 0.0% | 0.0% | 0.0% |
How might the approval of related-party transactions with Naxpar Pharma impact Parnax Lab's operational costs and profit margins in FY27?
What are the strategic implications of appointing Ladha Singhal & Associates for a five-year term regarding future audit consistency and regulatory compliance?
Could the reappointment of Mr. Mihir M. Shah signal any upcoming shifts in corporate governance or leadership strategy at Parnax Lab?

































